Abstract
The channel kinases TRPM6 and TRPM7 have recently been discovered to play important roles in Mg2+ and Ca2+ homeostasis, which is critical to both human health and cell viability. However, the molecular basis underlying these channels’ unique Mg2+ and Ca2+ permeability and pH sensitivity remains unknown. Here we have created a series of amino acid substitutions in the putative pore of TRPM7 to evaluate the origin of the permeability of the channel and its regulation by pH. Two mutants of TRPM7, E1047Q and E1052Q, produced dramatic changes in channel properties. The I–V relations of E1052Q and E1047Q were significantly different from WT TRPM7, with the inward currents of 8- and 12-fold larger than TRPM7, respectively. The binding affinity of Ca2+ and Mg2+ was decreased by 50- to 140-fold in E1052Q and E1047Q, respectively. Ca2+ and Mg2+ currents in E1052Q were 70% smaller than those of TRPM7. Strikingly, E1047Q largely abolished Ca2+ and Mg2+ permeation, rendering TRPM7 a monovalent selective channel. In addition, the ability of protons to potentiate inward currents was lost in E1047Q, indicating that E1047 is critical to Ca2+and Mg2+ permeability of TRPM7, and its pH sensitivity. Mutation of the corresponding residues in the pore of TRPM6, E1024Q and E1029Q, produced nearly identical changes to the channel properties of TRPM6. Our results indicate that these two glutamates are key determinants of both channels’ divalent selectivity and pH sensitivity. These findings reveal the molecular mechanisms underpinning physiological/pathological functions of TRPM6 and TRPM7, and will extend our understanding of the pore structures of TRPM channels.
TRPM6 and TRPM7 belong to the TRP channel superfamily (1–5) and are distinguished from other known ion channels by virtue of having both ion channel and protein kinase activities (6–11). In addition, TRPM6 and TRPM7 uniquely exhibit strong outward rectification, permeation to Ca2+, Mg2+, monovalent cations, and a wide array of trace metals (6–8, 11, 12). The channel activity of TRPM7 is regulated by intracellular Mg2+(7) and other divalent cations (13–15), Mg2+-ATP (7, 12, 16), phosphatidylinositol 4,5-bisphosphate (14, 17), cAMP (18), and internal and external pH conditions (14, 19). Similarly, TRPM6 channel activities have been shown to be inhibited by intracellular Mg2+ and potentiated by external protons (8, 11). Recent studies have demonstrated that TRPM6 and TRPM7 are key regulators of Mg2+ homeostasis: mutations of TRPM6 cause familial hypomagnesemia and secondary hypocalcemia (20, 21); whereas targeted gene deletion of TRPM7 in the DT40 B cell line produced intracellular Mg2+ deficiency and growth arrest (7, 22). Consistent with its role in Mg2+ and Ca2+ homeostasis, TRPM6 is abundantly expressed in the intestine and the kidney (8, 20, 21, 23), whereas TRPM7 is ubiquitously expressed, with highest expression in the kidney and heart (5, 6). In addition to these channels’ regulation of Mg2+ homeostasis, several studies have suggested multiple cellular and physiology functions for TRPM7, including anoxic neuronal death (24), cell adhesion and actomyosin contractility (25, 26), and skeletogenesis (27). Although the mechanisms by which TRPM6 and TRPM7 exert their physiological and/or pathological functions are not yet completely understood, it is clear that permeation of Ca2+ and Mg2+ contributes substantially to the known functions of these channels (7, 20–22, 24, 25, 27). Moreover, a recent study demonstrated that the sensitivity of TRPM7 to external pH may contribute to controlling neurotransmitter release (28). Therefore, it is essential to understand the molecular mechanisms underlying the Ca2+ and Mg2+ permeability of TRPM6 and TRPM7, as well as their sensitivities to changes in pH.
The aim of the present study was to identify the amino acid residues that determine Mg2+ and Ca2+ permeation of TRPM6 and TRPM7. We previously demonstrated that external protons significantly enhance TRPM6 and TRPM7 inward currents (11, 19) by decreasing the divalent affinity to the channels. Our results suggested that protons compete with divalents for binding site(s) within the channels’ pore. In the present study, we systematically mutated negatively charged amino acid residues within the putative pore-forming region of TRPM7; and identified Glu1047 and Glu1052 of TRPM7 as the key residues that confer divalent selectivity and the sensitivity of the channel to pH. Moreover, we demonstrated that mutations of the equivalent positions (Glu1024 and Glu1029) in TRPM6 produced identical changes, indicating that these two glutamate residues constitute the molecular basis of these channels’ Mg2+ and Ca2+ permeability as well as their pH sensitivity. The above findings are critical to understanding the physiological/pathological functions of TRPM6 and TRPM7, and provide molecular insight of the pore architecture of these channels.
EXPERIMENTAL PROCEDURES
Molecular Biology
TRPM6 construct was kindly provided by Dr. Joost G. J. Hoenderop. TRPM7 was previously cloned from mouse (6). Amino acid substitutions to the pores of TRPM6 and TRPM7 were made using the QuikChange Site-directed Mutagenesis Kit (Stratagene) following the manufacturer’s instructions. The primers are shown in supplemental materials Table S1.
Functional Expression of TRPM6, TRPM7, and the Mutants
CHOK1 cells were grown in Dulbecco’s modified Eagle’s medium/Ham’s F-12 medium supplemented with 10% fetal bovine serum, 100 units/ml penicillin, and 100 mg/ml streptomycin at 37 °C in a humidity-controlled incubator with 5% CO2. Cells were transiently transfected with wild-type (WT)5 TRPM6, TRPM7, and the mutants of TRPM6 and TRPM7 as previously described (6). TRPM7 and its mutants were co-transfected with a green fluorescent protein-containing pTracerCMV2 vector. Electrophysiological recordings were conducted between 36 and 48 h after transfection. Successfully transfected cells were identified by their green fluorescence when illuminated at 480 nm. All patch-clamp experiments were performed at room temperature (20–25 °C).
Electrophysiology
Whole cell currents were recorded using an Axopatch 200B amplifier. Data were digitized at 10 or 20 kHz, and digitally filtered off-line at 1 kHz. Patch electrodes were pulled from borosilicate glass and fire-polished to a resistance of ~3 MΩ when filled with internal solutions. Series resistance (Rs) was compensated up to 90% to reduce series resistance errors to <5 mV. Cells in which Rs was >10 MΩ were discarded (29).
For whole cell current recordings, voltage stimuli lasting 250 ms were delivered at 1–5-s intervals, with either voltage ramps or voltage steps ranging from −120 to +100 mV. Unless otherwise stated, following break-in, 3–5 min were allowed to pass to let currents develop to reach a steady-state. A fast perfusion system was used to exchange extracellular solutions, with complete solution exchange achieved in ~1–3 s (19).
The internal pipette solution (P1) for whole cell current recordings contained (in mM) 145 cesium methanesulfonate, 8 NaCl, 10 EGTA, and 10 HEPES, with pH adjusted to 7.2 with CsOH. In some experiments (supplementary materials Fig. S1), Mg2+ was added to the pipette solution and the free Mg2+ concentration was titrated to 3 mM (calculated with the MaxChelator software, available at stanford.edu/~cpatton/webmaxcS.htm). In experiments designed to diminish outward currents, pipette solution (P2) contained (mM): NMDG 120, glutamic acid 108, HEPES 10, EGTA 10, CsCl 10, and pH was adjusted to 7.2 with NMDG.
The standard extracellular Tyrode’s solution contained (mM): 140 NaCl, 5 KCl, 2 CaCl2, 20 HEPES, and 10 glucose, pH adjusted to 7.4 (NaOH). External solutions at various acidic pH were prepared as previously reported (19, 30–32). In brief, HEPES (20 mM) was used in the solutions at pH 7.0 and 7.4, and was replaced by 10 mM HEPES and 10 mM MES for the solutions at pH ≤6. Divalent-free solution (DVF) contained (mM) 145 NaCl, 20 HEPES, 5 EGTA, 2 EDTA, and 10 glucose, with estimated free [Ca2+] <1 nM and free [Mg2+] ≈10 nM at pH 7.4 (calculated with the MaxChelator software). Appropriate Ca2+ or Mg2+ was added to the DVF at pH 7.4 to prepare solutions containing ≤10 μM Mg2+ or Ca2+ (Fig. 5). Solutions containing 0.1, 0.2, 0.5, 1, 2, and 10 mM Mg2+ or Ca2+ were prepared by omitting EDTA and EGTA in the DVF solution, and by adding the appropriate concentrations of Mg2+ or Ca2+, with reductions in Na+ concentration when necessary to maintain constant osmolarity. Isotonic Ca2+ or Mg2+ solution contained 120 mM Ca2+ or Mg2+, 10 mM HEPES, 10 mM glucose, with pH adjusted to pH 7.4. Different cation solutions (Fig. 7) at 30 mM contained (in mM): 30 divalents or monovalents, 20 HEPES, 100 NMDG-Cl, 10 glucose (pH 7.4). Zn2+ solution was prepared at 10 mM due to the low solubility (11). All chemical reagents were purchased from Sigma.
FIGURE 5. Changes in affinity of Ca2+ and Mg2+ in TRPM7 mutants.
A–C, representative recordings of WT TRPM7, E1052Q, and E1047Q obtained in the external solutions containing 1 nM (DVF), 1, 10, 200, and 500 μM Ca2+, and in 2 mM Ca2+ Tyrode solutions, respectively. D–F, typical currents of WT TRPM7, E1052Q, and E1047Q recorded in 1 nM, 1, 10, 200, or 500 μM Mg2+ containing solutions, and in 2 mM Ca2+ Tyrode solution, respectively. G and H, dose-response curves of Ca2+ and Mg2+ for WT TRPM7 and its mutants. The IC50 values obtained by best fit with the Hill equation for the Ca2+ block were (μM): 4.1 ± 0.2 (nH =0.96, n = 10) for WT TRPM7, 3.3 ± 0.1 (nH = 1.7, n = 7) for D1035N, 593.6 ± 69.9 (nH = 0.8, n = 5) for E1047Q, 202.2 ± 14.3 (nH = 0.9, n = 7) for E1052Q, and 2.9 ± 1.3 (nH =1.5, n =8) for D1054A, respectively. The IC50 values for Mg2+ block were (μM): 3.6±0.4 (nH = 0.7, n = 8) for TRPM7, 7.4± 0.8(nH = 0.8, n= 7) for D1035N, 442.9 ± 53.6 (nH = 0.6, n = 6) for E1047Q, 154.7 ± 23.4 (nH = 0.6, n = 6) for E1052Q, and 3.6 ± 0.2 (nH = 0.7, n = 8) for D1054A, respectively.
FIGURE 7. Changes in divalent permeability of TRPM7 mutants (mean ±S. E.,n =6).
A–E, currents recorded under the indicated conditions were normalized to the current amplitude value obtained in 30 mM Ca2+ external solutions. The sequence of monovalent permeability was not changed (K+>Cs+>Na+) in the mutants compared with WT TRPM7; however, the monovalent permeabilities in E1047Q were significantly larger than that of WT TRPM7. F, currents obtained in 30 mM Ca2+ or Mg2+ were normalized to the current amplitude obtained in Tyrode solution. Note that the ratios of ICa/ITyrode and IMg/ITyrode for E1047Q were 0.014 and 0.0096, respectively. The ICa(E1047Q)/ICa(TRPM7) was 0.023, and IMg(E1047Q)/IMg(TRPM7) was 0.011, respectively.
Ion permeation ratios are typically calculated from reversal potentials (Erev) using Nernst and Goldman-Hodgkin-Katz equations based on the assumption that ions permeate independently and that the electric field in the membrane is constant (33). For TRPM7 channels, however, because the monovalent and divalent cations do not permeate the channels independently (7), it is not adequate to use the Goldman-Hodgkin-Katz equation to estimate the relative permeability (7, 8, 12). Thus, the relative permeability was estimated from the inward current amplitude as previously reported (8, 12).
Data Analysis
Pooled data are presented as mean ± S.E. Dose-response curves were fitted by an equation of the form: E = Emax {1/[1 + (EC50/C)n]}, where E is the effect at concentration C, Emax is the maximal effect, EC50 is the concentration for half-maximal effect, and n is the Hill coefficient (34). EC50 is replaced by IC50 if the effect is an inhibitory effect. Voltage-dependent effects of Ca2+ and Mg2+ on TRPM7 and the mutants were analyzed by fitting the I/I0 ratio curves to the Boltzmann functions: I/I0 = 1/(1 + exp[V0.5 − V]/k) is for the voltage-dependent block, and I/I0 = 1/(1 + exp[V − V0.5]/k) is for the voltage-dependent relief of block; where I0 is the current before and I is the current after application of Mg2+ or Ca2+, V is the membrane potential, V0.5 is the membrane potential at which the current is blocked by 50%, and k is a slope factor representing the voltage dependence of block (35). The slope factor k is k = RT/zδF, where z is the valence of blocker and δ is the fraction of the membrane electrical field. Statistical comparisons were made using two-way analysis of variance and two-tailed t test with Bonferroni correction; p < 0.05 indicated statistical significance.
RESULTS
E1047Q and E1052Q Substitutions within TRPM7 Pore Alters Its I–V Relationship
When heterologously expressed, TRPM7 constitutes a channel that is characterized by extremely small inward and large outward currents. External divalent cations such as Mg2+ and Ca2+ are permeable to TRPM7 and at the same time block monovalent cations permeating through the pore of the channel. We have previously shown that external protons substantially potentiate TRPM7 inward currents, which may occur through competition of protons with divalent cations for binding sites in the pore of the channel (19). To identify potential binding sites for Mg2+, Ca2+, as well as for protons, we systematically exchanged negatively charged residues within the TRPM7 putative pore region with uncharged residues found at equivalent positions in other TRPM family members (Fig. 1). As the increase in inward current induced by pH for TRPM6 is smaller than that observed for TRPM7 (11, 19), we also investigated the contribution of His1039 to the pH sensitivity of TRPM7 because His1039 is replaced by Glu in TRPM6. Therefore, we additionally mutated His1039 to H1039E and H1039M, as TRPM1 and TRPM3 have a Met residue at the equivalent positions, respectively. Within the S5–S6 linker of TRPM7, eight residues were singly or doubly mutated (Fig. 1). The resulting TRPM7 mutants were transiently transfected into CHO-K1 cells and their currents examined for sensitivity to pH and permeability to Mg2+ and Ca2+. Because the endogenous TRPM7-like MIC/MagNuM current is extremely small in CHO-K1 cells (6), the elicited currents obtained upon transfection of the TRPM7 mutants predominantly reflect conductances originating from the expressed TRPM7 pore mutants.
FIGURE 1. Alignment of TRPM7 pore region with other TRPM channels.
A, schematic structure of the TRPM7 and positions of substituted amino acid residues in the TRPM7 channel. B, alignment of pore region of TRPM channels. Amino acids in boxes are the ones that were selected for analysis. The GenBank™ accession numbers of the mouse TRPM7, human TRPM1– 6, and TRPM8 are AF376052, AAC8000, AAI12343; NP_060106, NP_055370, Q9BX84; and NP_076985, respectively.
Fig. 2 shows currents recorded from various TRPM7 mutants. The current-voltage (I–V) relationships of the mutants D1035N, D1054A, H1039E, and H1039E were similar to that of WT TRPM7. It was surprising that D1054A did not produce a significant change, as this aspartic acid residue is conserved among all TRPM channels. By contrast, the I–V relationships of E1047Q and E1052Q were significantly different from that of WT TRPM7. The inward current of E1052Q was substantially larger than that of WT TRPM7, whereas its outward current was similar to WT TRPM7. E1047Q demonstrated a double rectification I–V profile, with increased inward current and decreased outward current compared with WT TRPM7. The normalized I–V curves of D1035N, D1054A, H1039E, and H1039M were superimposable with that of WT TRPM7, whereas the I–V curves of E1047Q and E1052Q were markedly different from that of WT TRPM7 (Fig. 2H). The average inward and outward current amplitudes obtained for the TRPM7 pore mutants are summarized in Fig. 3A. The ratios of inward currents measured at −120 mV to the outward currents measured at +100 mV of E1047Q and E1052Q were 12- and 8-fold larger than that of WT TRPM7 (Fig. 3B), respectively; indicating that blockade of monovalent inward current by divalent cations was reduced in E1047Q and E1052Q compared with WT TRPM7. The significant changes in current-voltage profiles in E1047Q and E1052Q indicate that E1047 and E1052 are residues critical to TRPM7 channel function.
FIGURE 2. Current-voltage relationships of WT TRPM7 and its mutants.
A–G, representative currents elicited by ramp protocols ranging from −120 to +100 mV in WT TRPM7 and its mutants. Note the significant changes in the I–V relation of E1047Q (E) and E1052Q (F). H, normalized I–V curves of WT TRPM7 and its mutants. The I–V curves of D1035N, H1039E, H1039M, and D1054A show outward rectification, and are superimposed with that of WT TRPM7; whereas E1047Q exhibits double-rectification with significantly increased inward currents and markedly decreased outward currents. Inward current of E1052Q is substantially larger than that of WT TRPM7.
FIGURE 3. Average current amplitudes of WT TRPM7 and its mutants.
A, mean outward(top)and inward (bottom)current amplitudes measured at +100 and −120 mV, respectively(n =8).B, ratios of inward versus outward current amplitude (n =8).
In the mutants in which the negatively charged Glu was replaced by positively charged Lys at Glu1047 and Glu1052 positions (E1047K and E1052K), a majority of cells transfected with E1047K and E1052K did not produce measurable currents (data not shown). We were unable to detect expression of the E1052K mutant, suggesting that the amino acid substitution may have affected the overall stability of the protein. However, expression of E1047K was confirmed by Western blot analysis (data not shown), suggesting that either the E1047K mutant is completely inactive or unable to traffic to the cell membrane, thereby indicating that Glu1047 is essential for TRPM7 channel function.
Changes in pH Sensitivity in TRPM7 Mutants
For the WT TRPM7 channels, acidification of extracellular bath solution increased the inward current by about 12-fold when the pH was lowered from pH 7.4 to 4.0 (Fig. 4, A1–A2). Similar increases in the inward currents were observed in the H1049E and H1039M mutants (Fig. 4, F1–F2 and G1–G2). The magnitude of the increase in inward current by acidic external bath solutions was considerably smaller for mutants E1052Q, D1035N, and D1054A. However, no significant difference in pH1/2 (Fig. 4, A3 and C3–G3) was obtained for D1035N, H1039E, H1039M, D1054A, and E1052Q mutants compared with WT TRPM7. Surprisingly, unlike WT TRPM7 and the other pore mutants, external protons inhibited E1047Q currents in a concentration-dependent manner (Fig. 4B1). The maximal inhibition was about 30%, with an IC50 of pH 5.4. This unexpected result indicates that Glu1047 substantially contributes to proton binding, and is therefore likely to be the major binding site for divalent cations.
FIGURE 4. Effects of acidic pH on WT TRPM7 and its mutants.
A1–G1, changes in the inward currents by acidification of external solutions. Current amplitudes were measured at −120 mV at the indicated pH and normalized to the amplitude obtained at pH 7.4. Note that E1047Q currents were inhibited by acidic pH solutions, with maximal inhibition of ~30% at pH 4.0. A2–G2, representative recordings of WT TRPM7 and its mutants obtained in the external solutions at pH 7.4 and 4.0. A3–G3, concentration-dependent effects of protons on WT TRPM7 and its mutants. The changes in current amplitude at the indicated pH were normalized to the maximal change in current amplitude. Average data were fitted with the Hill equation with average parameters obtained from best fits to individual cells. The 50% potentiation pH (pH1/2) and Hill coefficient were pH1/2 = 4.5 ± 0.5 (nH = 1.2, n = 7) for WT TRPM7; pH1/2 = 4.1 ±0.2 (nH = 0.8, n =5) for D1035N; pH1/2 = 4.5 ± 0.4 (nH = 0.9, n = 5) for E1052; pH1/2 = 4.7 ± 0.8 (nH = 2.1, n = 6) for D1054A; pH1/2 = 4.2 ± 0.4 (nH = 1.1, n = 9) for H1039E; and pH1/2 = 4.6 ±0.6 (nH = 1.4, n =8) for H1039M; respectively. E1047Q inward currents were blocked by low pH, with the 50% inhibition pH of pH1/2 = 5.4 ±0.7 (nH = 0.9, n = 5).
Mutations at Glu1047 and Glu1052 Change the Affinity of TRPM7 for Divalent Cations
We next examined whether the divalent affinity for TRPM7 was changed when negatively charged residues in the putative pore region of the channels were mutated to uncharged amino acids. The inward current of WT TRPM7 carried by monovalent cations can be blocked by micromolar concentrations of Ca2+ or Mg2+ (Fig. 5, A and D), with the IC50 values of 4.1 ± 0.2 (Fig. 5G) and 3.6 ± 0.4 μM (Fig. 5H), respectively. Monovalent currents produced by D1035N and D1054A were similarly blocked by Ca2+ and Mg2+, with the IC50 values nearly identical to those of WT TRPM7 (Fig. 5, G–H). The dose-response curves (Fig. 5, G–H) of D1035N and D1054A were superimposable with those of WT TRPM7. Unlike D1035N and D1054A, higher concentrations of Ca2+ and Mg2+ were required to block monovalent currents produced by E1047Q and E1052Q (Fig. 5, B, E, C, and F). The dose-response curves for E1047Q and E1052Q were markedly shifted to the right, with IC50 values increased by 50- (E1052Q) to 140-fold (E1047Q) compared with WT TRPM7. These results indicate that the affinities of Ca2+ and Mg2+ for the TRPM7 mutants E1047Q and E1052Q were significantly decreased, indicating that Glu1047 and Glu1052 residues are critical sites for Ca2+ and Mg2+ binding.
We also tested the effects of Ca2+ and Mg2+ on the monovalent currents of H1039E and H1039M. The IC50 values of the Ca2+ block were 2.3 ± 0.4 μM (n =6, nH = 1.0) and 2.6 ± 0.5 μM (n = 6, nH = 1.0) for H1039M and H1039E, respectively; whereas the IC50 values for the Mg2+ block were 3.4 ± 0.6 μM (n =6, nH = 0.7) and 3.5 ± 0.4 μM (n = 6, nH = 0.8) for H1039M and H1039E, respectively. No statistical significant difference in IC50 values of Ca2+ and Mg2+ block of H1039M and H1039E was observed as compared with WT TRPM7, indicating that the His1039 residue is not essential for Ca2+ or Mg2+ binding to TRPM7.
Changes in Voltage-dependent Block by Mg2+ and Ca2+ in Mutants E1047Q and E1052Q
It has been shown that divalent cations block monovalent currents of MIC/MagNuM and TRPM7 in a voltage-dependent manner (35, 36). We therefore compared the voltage-dependent effects of Ca2+ and Mg2+ on monovalent currents of WT TRPM7, E1047Q, and E1052Q. As shown in Fig. 6, WT TRPM7 monovalent current was the most potently blocked at −40 mV (Fig. 6, A and D) with an IC50 of 1.0 μM (Fig. 6A), whereas the IC50 values at −120, −80, +40, and +80 mV were 3.6, 1.8, 51.5, and 1573 μM, respectively. The smaller inhibition or the relief of Mg2+ inhibition on TRPM7 at hyperpolarized potentials (Fig. 6, A, D, and G) may suggest “punch-through” of Mg2+ to the inside, consistent with the notion that Mg2+ is a permeant blocker for TRPM7 (35). The best fit of Mg2+ block with a Boltzmann equation estimated the equivalent electrical distance across the δ membrane from the extracellular side (δout) to be 0.84 for Mg2+ (Fig. 6G and supplementary materials Table S2), indicating that extracellular Mg2+ binds to TRPM7 at a site of 84% of the membrane electrical field. The Boltzmann equation fit to the relief of the Mg2+ block yielded the fractional electrical distance δ from the intracellular side (δin) to be 0.25. The fact that our calculated δout and δin values do not add up to exactly 1.0 could be explained in several ways, including: 1) there may be multiple Mg2+ ions binding to the pore (33); 2) the blocking ion Mg2+ may compete with permeating ion Na+; 3) there may be conformational changes of the channel caused by binding of the blocking ions; and 4) there may be coupled movement of the blocking ion and permeant ion through the ion channels (33, 35, 37).
FIGURE 6. Voltage-dependent effects of Mg2+ on monovalent currents of WT TRPM7, E1047Q, and E1052Q.
A–C, dose-response curves for the inhibition of inward monovalent currents by Mg2+ at the indicated voltages for WT TRPM7 (A), E1047Q (B), and E1052Q (C). D–F, the IC50 values obtained by best fit with the Hill equation at various voltages (n = 8 for TRPM7; n = 6 for E1047Q and E1052Q, respectively). G–I, current ratios (I/I0) of TRPM7 (G), E1047Q (H), and E1052Q (I) in the presence of various Mg2+ concentrations, respectively. Note the relief of Mg2+ block at hyperpolarized potentials observed in TRPM7 and E1052Q, but not in E1047Q. Dotted lines represent I/I0, where I is the current in the presence of Mg2+, and I0 is the current in DVF solution. Solid lines represent the best fit of the current ratio to the Boltzmann functions (see “Experimental Procedures”). In G, for the voltage-dependent block on TRPM7, V0.5 values for 3 (blue), 10 (red), and 100 (green) μM Mg2+ were 0.3, 20.9, and 40.6 mV, respectively; the values of k(depol) were almost identical, with 15.2 mV at 3 μM Mg2+, 15.5 mV at 10 μM Mg2+, and 15.6 mV at 100 μM Mg2+, respectively; for the voltage-dependent relief of block on TRPM7, V0.5 for 3 and 10 μM Mg2+ were −64.9 and −124.2 mV, respectively, and the values of k(hyperpol) were 49.8 and 50.4 mV, respectively. In H, Boltzmann fit of the voltage-dependent block on E1047Q at 500 μM (blue), 10 mM (red), and 20 mM(green) Mg2+ generated V0.5 values of −39.3, −27.5, and −16.3 mV, respectively; and k(depol) values of 36.2, 35.8, and 35.6 mV, respectively. In I, for voltage-dependent block on E1052Q at 150 μM (blue), 1 mM (red), and 5 mM (green) Mg2+, the V0.5 values were 2.5, 15.2, and 50.6 mV, respectively; and k(depol) values were 24.5, 24.3, and 24.4 mV, respectively. For voltage-dependent relief of Mg2+ block on E1052Q, the V0.5 values were −87.7 and −95.4 mV at 150 μM, and 1 mM Mg2+, respectively, and k(hyperpol) values were 29.1 and 29.0 mV at 150 μM and 1 mM Mg2+, respectively. The fraction of the membrane electrical field δout calculated from k(depol) based on k = RT/zδF was 0.84 for TRPM7, 0.36 for E1047Q, and 0.52 for E1052Q, respectively (see supplementary materials Table S2).
Similar to WT TRPM7, E1052Q also exhibited a voltage-dependent block by Mg2+ (Fig. 6, C, F, and I), albeit the voltage dependence was less dramatic compared with that of WT TRPM7, as evidenced by the shallower slope of I/I0 curves (Fig. 6I). The best fit of the voltage-dependent block with a Boltzmann function yielded the equivalent electrical distance across the membrane δout of 0.52 (Fig. 6I), indicating that a Mg2+ binding site in E1052Q is located close to the outside surface of the membrane. The Boltzmann equation fit to the relief of the voltage-dependent block on E1052Q yielded δin of 0.43 (supplementary materials Table S2). In contrast to WT TRPM7 and E1052Q, the Mg2+ block on E1047Q was barely relieved at hyperpolarizing potentials as evidenced by the flat I/I0 curves at negative potentials (Fig. 6H) and the virtually identical IC50 values at −120, −80, and −40 mV (Fig. 6, B and E), indicating that the blocking ion Mg2+ encounters a large energy barrier and cannot penetrate all the way through the pore (38). Thus, E1047Q may not be able to support measurable Mg2+ currents. The best fit of the voltage-dependent block of Mg2+ on E1047Q with the Boltzmann equation estimated the fractional electrical distance across the membrane δout of 0.36, suggesting that Mg2+ binds to a shallow site (Fig. 6) with low affinity (Figs. 5 and 6) in E1047Q.
The voltage- and concentration-dependent effects of Ca2+ on TRPM7, E1047Q, and E1052Q were similar to the effects of Mg2+. The IC50 values of the Ca2+ block on TRPM7 monovalent currents were 4.1 ± 0.2 μM at −120 mV, 1.9 ± 0.4 μM at −80 mV, 0.9 ± 0.2 μM at −40 mV, 93.9 ± 12.1 μM at +40 mV, and 1.3 ± 0.2 mM at +80 mV (n = 6 at each concentration), respectively; the IC50 values of Ca2+ block on monovalent currents of E1047Q were 593.6 ± 69.9 μM at −120 mV, 578.1 ±63.4 μM at −80 mV, 561.8 ± 73.6 μM at −40 mV, 5.9 ± 0.6 mM at +40 mV, and 7.6 ± 0.7 mM at +80 mV (n = 6), respectively; and Ca2+ block on monovalent currents of E1052Q were 202.2 ± 14.3 μM at −120 mV, 132.5 ± 14.7 μM at −80 mV, 67.2 ± 8.2 μM at −40 mV, 312.1 ± 25.7 μM at +40 mV, and 1.3 ±0.2 mM at +80 mV, respectively. The values of the fractional electrical distance δout calculated based on k = RT/zδF were 0.81, 0.33, and 0.56 for TRPM7, E1047Q, and E1052Q, respectively (supplemental materials Table S2).
We further examined if E1047Q and E1052Q affected the ability of internal Mg2+ to block TRPM7 currents. We found that mutations at Glu1047 and Glu1052 did not change internal Mg2+ inhibition on TRPM7 currents (supplemental materials Fig. 1), indicating that these residues are not the binding sites for internal Mg2+. This is consistent with the notion that internal Mg2+ is not accessible to the channel pore, because internal Mg2+ blocks TRPM7 in a voltage-independent manner (15). A model proposed in a recent study also suggests that the internal Mg2+ binding sites are located in the C terminus of TRPM7: one site is located in the kinase domain and the second site is located upstream of the kinase domain (39).
Changes in Relative Permeability by Mutations at Glu1047 and Glu1052
The larger inward currents observed in E1052Q and E1047Q mutants (Fig. 2) and their reduced apparent affinity for Ca2+ and Mg2+ (Fig. 5 and 6) prompted us to determine whether the relative permeability of these mutants to Ca2+, Mg2+, and other divalent cations were altered as well (11, 12). We assessed the relative permeability by evaluating changes in the current amplitude as previously reported (7, 8, 12). Divalent cations at 30 mM were used to achieve larger inward currents so that more precise measurements of the relative permeability could be obtained. Zn2+ was prepared at 10 mM due to its low solubility at pH 7.4 (11). Fig. 7, A–E, shows the ratios of current amplitude of the indicated cations normalized to the current amplitude measured in the solution containing 30 mM Ca2+. The mutants D1035N and D1054A exhibited substantial permeation to different divalents with a relative permeability to different cations similar to that observed for WT TRPM7 (Fig. 7, A, B, and E). In contrast with D1035N and D1054A, E1052Q exhibited a decreased divalent permeability, as was evident from the ratio of ITyrode/ICa being substantially larger than that of INi/ICa (Fig. 7D). In addition, Ba2+ permeation through E1052Q appeared smaller than that of WT TRPM7, D1035N, and D1054A (Fig. 7, A–D). Nevertheless, all the tested divalents permeated through E1052Q. Intriguingly, E1047Q exhibited very little permeation to the divalents such that Mg2+, Ca2+, and Zn2+ currents were barely detectable (Fig. 7C). By contrast, the ratio of ITyrode/ICa for E1047Q was significantly larger than that for WT TRPM7 and other mutants, indicating that currents through E1047Q in Tyrode solutions were mainly carried by monovalent cations. Fig. 7F shows the normalized Mg2+ and Ca2+ currents versus the current amplitude obtained in Tyrode solution. In E1047Q, the current amplitude of Mg2+ and Ca2+ was only 1.1 and 2.3% of that observed in WT TRPM7, respectively. In E1052Q, the current amplitude carried by Mg2+ and Ca2+ was 24.3 and 24.1% of that observed in WT TRPM7, respectively. These results strongly suggest that Glu1047 is the dominant residue that confers Ca2+ and Mg2+ permeability to TRPM7. In contrast to the changes to divalent permeability, the sequence for monovalent permeability (K+>Cs+>Na+) (Fig. 7, A–E) was not changed in all the mutants tested compared with WT TRPM7.
Mutation of Glu1047 Diminishes Ca2+ Permeation and Largely Eliminates Mg2+ Permeation
We further studied the Ca2+ and Mg2+ permeation properties of E1047Q and E1052Q using isotonic Ca2+ and Mg2+ solutions (120 mM Ca2+ or Mg2+). Currents were recorded using a P2 pipette solution to minimize outward currents. In WT TRPM7, the inward current amplitude in isotonic Ca2+ and Mg2+ solutions was similar to that in Tyrode solution or in 2 mM Ca2+, 150 mM monovalent solutions (Fig. 8, A, D, and G). Changes in reversal potentials of TRPM7 in isotonic Ca2+ and Mg2+ solutions were also similar to those in 2 mM Ca2+/monovalent solutions (Fig. 8J). In clear contrast to WT TRPM7, the inward current amplitude of E1047Q in isotonic Ca2+ and Mg2+ solutions was significantly smaller than those in 2 mM Ca2+ Tyrode solution (Fig. 8, B and E). There was almost no Mg2+ conductance in isotonic Mg2+ solution, as shown in Fig. 8, B and E. The average current amplitude shown in Fig. 8H also indicates that the Ca2+ current was significantly reduced, whereas the Mg2+ current was almost undetectable in the E1047Q mutant. The isotonic Mg2+ and Ca2+ current amplitude of E1047Q (Fig. 8H) was 2.1 and 6.0% of the current amplitude of WT TRPM7 (Fig. 8G), respectively. Consistent with the small conductances in the isotonic solutions, the reversal potentials of E1047Q in isotonic Ca2+ and Mg2+ solutions were much more negative than that in Tyrode solution (Fig. 8, B and K). Unlike E1047Q, E1052Q exhibited substantial inward Ca2+ and Mg2+ currents (Fig. 8, C, F, and I), albeit the current amplitude was smaller compared with that of WT TRPM7. Changes in reversal potentials under the indicated conditions in reference to the value obtained in Tyrode solution were smaller than those of WT TRPM7 (Fig. 8J), but much larger than those of E1047Q (Fig. 8L). Based on the above results, we conclude that E1047Q and E1052Q are critical for Mg2+ and Ca2+ permeation through TRPM7.
FIGURE 8. E1047Q diminishes Ca2+ permeation and eliminates Mg2+ permeation.
A–C, representative currents of TRPM7, E1047Q, and E1052Q elicited by ramp protocols in 2 mM Ca2+/Tyrode, NMDG, isotonic Ca2+, and isotonic Mg2+ solutions, respectively. P2 pipette solution containing reduced Cs+ concentration (10 mM) was used. D–F, inward currents measured at −120 mV under different conditions in the representative cells for TRPM7 (D), E1047Q (E), and E1052Q (F). G–I, average current amplitudes (mean ±S.E., n =6) measured at −120 mV under the indicated conditions for TRPM7, E1047Q, and E1052Q. J–L, changes in reversal potentials of TRPM7 (J), E1047Q (K), and E1052Q (L) (mean ± S.E., n =6). ΔErev was obtained by subtracting the reversal potential under indicated conditions by the reversal potential in Tyrode solution.
Mutations of Glu1024 and Glu1029 Changes Divalent Permeability and pH Sensitivity of TRPM6
The above results strongly suggest that Glu1047 and Glu1052 are key amino acid residues that confer Mg2+ and Ca2+ selectivity to TRPM7. To further confirm the importance of Glu1047 and Glu1052 in Ca2+ and Mg2+ permeation, we generated mutants E1024Q and E1029Q in TRPM6 at the equivalent positions for Glu1047 and Glu1052 in TRPM7, respectively. As shown in Fig. 9, A–C, TRPM6 mutants E1024Q and E1029Q exhibited significant changes in their I–V relationship compared with WT TRPM6. The normalized I–V curves (Fig. 9D) show that the ratios of inward currents at −120 mV versus outward currents at +100 mV of E1024Q (0.7) and E1029Q (0.3) were 14- and 6-fold larger than that of WT TRPM6 (0.05). The I–V relationships for E1029Q and E1024Q in TRPM6 were similar to the TRPM7 mutants E1052Q and E1047Q (Fig. 2).
FIGURE 9. Changes in Ca2+ and Mg2+ permeability in TRPM6 mutants E1024Q and E1029Q.
A–C, current-voltage relations for TRPM6, E1029Q, and E1024Q elicited by voltage ramps ranging from −120 to +100 mV. D, normalized I–V curves of TRPM6, E1029Q, and E1024Q. E and F, dose-response curves of Ca2+ and Mg2+ for TRPM6 and its mutants. The IC50 values obtained by best fit with the Hill equation for the Ca2+ block (E) were (μM): 4.6± 0.4 (nH = 0.8, n =10) for TRPM6, 153.5 ± 20.0 (nH=0.6, n =5) for E1024Q, and 50.5 ±9.0 (nH =0.5, n =5) for E1029Q, respectively. The IC50 values for Mg2+ block were (μM): 3.4 ±0.3 (nH = 0.7, n =8) for TRPM6, 237.2 ±26.2 (nH = 0.5, n =6) for E1024Q, and 149.2 ±19.2 (nH = 0.6, n =6) for E1029Q, respectively. G–I, inward current amplitude of TRPM6, E1024Q, and E1029Q measured at −120 mV under the indicated conditions. J, average current amplitudes of TRPM6, E1024Q, and E1029Q obtained in isotonic Ca2+ and Mg2+ solutions (120 mM) normalized to the current amplitude obtained in Tyrode solution.
We next determined whether the binding affinity of the TRPM6 pore mutants for divalents was changed. Similar to what we observed for E1047Q and E1052Q, the affinity of Ca2+ and Mg2+ was significantly decreased in TRPM6 mutants E1024Q and E1029Q (Fig. 9, E and F). The IC50 values of Ca2+ block of monovalent currents were 4.6 μM for TRPM6, 153.5 μM for E1024Q, and 50.5 μM for E1029Q, respectively; and IC50 values of Mg2+ block on monovalent currents were 3.4 ± 0.3 μM for TRPM6, 237.2 μM for E1024Q, and 149.2 μM for E1029Q, respectively. Consistent with the decreased affinity for Ca2+ and Mg2+, the permeation of Ca2+ and Mg2+ was also largely decreased. As shown in Fig. 9G, the inward current amplitude of the WT TRPM6 obtained in isotonic Ca2+ and Mg2+ solutions were similar to the current amplitude in Tyrode solution. By contrast, Ca2+ currents of E1024Q and E1029Q obtained in the isotonic solutions were significantly smaller than those obtained from WT TRPM6 (Fig. 9, G–I). Moreover, there was almost no Mg2+ permeation through E1024Q (Fig. 9, H and J). These results indicate that similar to Glu1047 and Glu1052 in TRPM7, Glu1024 and Glu1029 residues are essential for the Mg2+ and Ca2+ permeability of TRPM6.
As TRPM6 is sensitive to acidic pH (11), we next tested if the pH sensitivity was changed in mutants E1024Q and E1029Q. As shown in Fig. 10, external protons enhanced inward currents of E1029Q (Fig. 10, C, F, and I). The degree of increase in E1029Q inward currents was smaller than the increase in TRPM6 inward current induced by low pH, but similar to the changes in E1052Q (Fig. 4, C1–C3). In contrast to E1029Q, E1024Q was blocked by acidic external solutions by 42% at pH 3.0 (Fig. 10, B, E, and H) with an IC50 of pH 5.0. Thus, similar to what we found for residues Glu1047 and Glu1052 in TRPM7, TRPM6 residues Glu1024 and Glu1029 are critical determinants of the sensitivity of the channel to external pH.
FIGURE 10. Effects of external protons on TRPM6 and its mutants E1024Q and E1029Q.
A–C, representative recordings of TRPM6 (A), E1024Q (B), and E1029Q (C) obtained in the external solutions at pH 7.4 and 4.0. Note that E1024Q currents were blocked by low pH (B). D–F, changes in inward current amplitude measured at −120 mV at the indicated pH values. G–I, concentration-dependent effects of protons on TRPM6 (G), E1024Q (H), and E1029Q (I). Average data were fitted with the Hill equation with average parameters obtained from best fits to individual cells. The 50% potentiation pH (pH1/2) and Hill coefficient were pH1/2 = 4.3 ±0.4, nH = 0.7 (n =8) for TRPM6, and pH1/2 = 3.7 ±0.2, nH = 1.0 (n =5) for E1029Q, respectively; and the 50% inhibition pH (pH1/2) and Hill coefficient were pH1/2 = 5.0 ± 0.7, nH = 0.5 (n = 5) for E1024Q.
Double Mutant E1047Q/E1052Q Exhibits Similar Properties to Those of E1047Q
Because mutation of Glu1047 in TRPM7 produced dramatic changes in TRPM7 channel properties, and mutation of Glu1052 also generated substantial changes in Ca2+ and Mg2+ permeability as well as pH sensitivity, this prompted us to ask how mutation of both sites (E1047Q/E1052Q) would affect TRPM7 channel properties. Fig. 11A shows that the E1047Q/E1052Q current elicited by a ramp protocol exhibited a double rectifying I–V relation similar to that of E1047Q (Fig. 2, E and H). Like E1047Q, the inward currents in isotonic Ca2+ or Mg2+ solutions (120 mM) were almost undetectable (Fig. 11, B–D), and the reversal potentials of E1047Q/E1052Q in isotonic Ca2+ and Mg2+ solutions were almost identical to those in NMDG solutions (Fig. 11B), suggesting a largely reduced permeability to Ca2+ and Mg2+. Consistent with this notion, Mg2+ affinity for E1047Q/E1052Q was significantly smaller than that of WT TRPM7. At −120 mV, IC50 of the Mg2+ block on the monovalent currents of the double mutant was 132.7 μM (Fig. 11E). The voltage-dependent effect of Mg2+ on the E1047Q/E1052Q monovalent currents (Fig. 11, E and F) was also similar to that of E1047Q. IC50 values of Mg2+ block at −120, −80, and −40 mV were almost identical, indicating that there was no relief of Mg2+ block at hyperpolarizing potentials. Consistent with this notion, the current ratio (I/I0) and voltage relation (Fig. 11F) shows a virtually flat line at hyperpolarizing voltages, further suggesting that the punch-through mechanism of Mg2+ permeation had been disabled in E1047Q/E1052Q. The best fit of a Boltzmann equation to I/I0 curves produced a slope factor k of 29 mV, generating the estimated distance of the electrical field δout = 0.44 from the outside surface of the membrane. Similar to the effects of Mg2+, the IC50 values of Ca2+ block on E1047Q/E1052Q were 164.6 ± 20.7 μM at −120 mV, 170.3 ± 24.6 μM at −80 mV, 166.9 ± 26.7 μM at −40 mV, 723.1 ± 89.4 μM at +40 mV, and 2.4 ±0.3 mM at +80 mV, respectively (n = 5). The lack of voltage-dependent relief of Ca2+ block at hyper-polarized potentials further suggests the diminished divalent permeation through E1047Q/E1052Q. The above similar properties between E1047Q/E1052Q (Fig. 11) and E1047Q (Fig. 6) strongly suggest that, like the E1047Q mutation, double mutation of Glu1047 and Glu1052 largely eliminated a high-affinity divalent binding site that is present in the deep pore of WT TRPM7.
FIGURE 11. Changes in Mg2+ and Ca2+ permeability and pH sensitivity in the double mutant E1047Q/E1052Q of TRPM7.
A, typical recording of the E1047Q/E1052Q current elicited by a voltage ramp protocol ranging from −120 to +100 mV. B, currents of E1047Q/E1052Q recorded in Tyrode, NMDG, isotonic Ca2+ and Mg2+ (120 mM) solutions. Note the diminished inward currents in isotonic Ca2+ and Mg2+ solutions. C, inward current amplitude measured at −120 mV under various conditions. D, average current amplitudes at −120 mV in isotonic Ca2+ and Mg2+ solutions normalized to the current amplitude in the Tyrode solution. The current amplitude of E1047Q/E1052Q in isotonic Ca2+ and Mg2+ (120 mM) solutions was 0.1 ±0.06 and 0.08 ±0.04 (n = 6) of that in Tyrode solution, respectively. E, concentration-dependent effects of Mg2+ on E1047Q/E1052Q at various voltages. The IC50 values of Mg2+ were 132.7 ±25.6 μM at −120 mV, 135.2 ±17.3 μM at −80 mV, 138.4 ±41.3 μM at −40 mV, 632.3 ±76.7 μM at +40 mV, and 2.2± 0.4 mM at +80 mV, respectively (n =5). F, current ratio I/I0 at 100 μM and 2 mM Mg2+ plotted as a function of membrane potential. The best fit with the Boltzmann equation for voltage-dependent block of Mg2+ at 100 μM and 2 mM yielded the V50 values of −9.6 and 12.3 mV, respectively; and k values of 29.3 and 29 mV, respectively. The fraction of the membrane electrical field δout calculated based on k =RT/zδF was 0.44. G, effects of external protons on E1047Q/E1052Q. Inward current amplitude was increased by ~32% at pH 4.0. H, concentration-dependent effects of protons on E1047Q/E1052Q. The best fit with the Hill equation yielded pH1/2 of 3.5 ±0.1 (nH = 0.7, n = 5).
Unlike E1047Q currents, which were slightly inhibited by acidic external solutions (Fig. 4, B1–B3), the inward currents of the double mutant E1047Q/E1052Q were increased to a small degree by high concentrations of external protons (Fig. 11, E and F). This potentiation of inward currents of E1047Q/E1052Q by low pH was similar to that of E1052Q, although the degree of increase was much smaller than that in E1052Q. These results provide further evidence that residues Glu1047 and Glu1052 are indeed important in determining divalent permeability and pH sensitivity of TRPM7.
DISCUSSION
In the present study, we demonstrate that mutation of Glu1052 decreases its Ca2+ and Mg2+ permeability; whereas mutation of Glu1047 largely eliminates Ca2+ and Mg2+ permeability and converts TRPM7 into a monovalent selective cation channel. In addition, external protons, which significantly increase TRPM7 inward currents, fail to enhance the inward currents of E1047Q. Furthermore, mutations at the equivalent sites in TRPM6, E1024Q and E1029Q, produce similar phenotypic changes to those observed in E1047Q and E1052Q. These results indicate that Glu1047/Glu1052 in TRPM7 and Glu1024/Glu1029 in TRPM6 are essential for the Mg2+ and Ca2+ permeability and pH sensitivity of these channels.
Glu1047 and Glu1052 Are Key Amino Acid Residues That Determine Divalent Permeability and pH Sensitivity
A unique feature of TRPM6 and TRPM7 is their permeation of Ca2+ and Mg2+, which confers their physiological and pathological functions (7, 20–22, 24). Our previous study (11) suggested that negatively charged residues within the channel pore contribute to divalent permeability. In the present study, by systematically substituting the negatively charged residues in the putative pore region of TRPM7 with uncharged residues, we identified Glu1047 and Glu1052 as the key residues for Ca2+/Mg2+ permeability and pH sensitivity. This conclusion is supported by the fact that mutations at the equivalent positions in TRPM6 (Glu1024 and Glu1029) generated similar changes in divalent permeability and pH sensitivity. It is remarkable that neutralization of a single amino acid residue, E1047Q (or E1024Q), largely eliminated divalent permeation, converting the divalent selective TRPM7 (or TRPM6) to a virtually monovalent selective channel, and at the same time abolished external pH sensitivity. The feature that the divalent selectivity and pH sensitivity are conferred by the same residue in TRPM6 and TRPM7 is unique among TRP channels. It is known that TRPV5 (or TRPV6) is highly Ca2+ selective (34, 40) and also sensitive to external pH (41, 42). However, the pH sensitivity mediated by Glu522 in TRPV5 is independent of its Ca2+ selectivity determined by Asp542 (42, 43). TRPV1 channel activity is regulated by acidic pH through Glu600 and Glu648 residues (30), whereas its divalent permeability appears to be mediated by Asp646 (44). External low pH activates TRPV4 (45), yet it is unknown whether this pH sensitivity of the channel is correlated with its Ca2+ permeation determined by Asp672 and Asp682 residues in the pore (46). The monovalent selective channel TRPM5 is also inhibited by protons (47). Nonetheless, the molecular mechanism of pH sensitivity and divalent permeability of TRPM7/TRPM6 resembles to some extent the properties of the voltage-gated Ca2+ channels (VGCCs). It has been demonstrated that protons block VGCCs by binding to the Ca2+ binding sites, Glu residues, in the pore-forming region (48, 49). Mutation of Glu by Gln replacement in repeats I or III abolished the high-conductance state of VGCCs, as if the titration site had become permanently protonated (48). Like VGCCs, mutation of Glu1047 in TRPM7 (or Glu1024 in TRPM6) increased inward monovalent currents, resembling the effect produced when the external bath solution is acidified on WT TRPM7 (or TRPM6) currents (11). Furthermore, TRPM6 and TRPM7 lose their high affinity binding sites when Glu1024/Glu1047 and Glu1029/Glu1052 are replaced by Gln, similar to the loss of high affinity binding sites for divalent cations in VGCCs when the pore Glu residues are mutated (38).
It is noticeable that both E1047Q and E1052Q produced substantial changes in channel properties compared with WT TRPM7, although the changes such as I–V relation, decreased affinity to Ca2+ and Mg2+, and diminished divalent permeation in E1052Q are less dramatic than those observed in E1047Q. The double mutant E1047Q/E1052Q exhibited similar properties to those of E1047Q, suggesting that although both Glu1047 and Glu1052 are essential, Glu1047 dominates in determining divalent permeability and pH sensitivity. Using the Eyring rate model (35), Kerschbaum and colleagues predicted a high affinity site for binding Mg2+ within the electric field and two low affinity sites for MIC/TRPM7 channel. In agreement with this notion, our data indicate that Glu1047 and Glu1052 compose a high affinity binding site. Mutation of either or both of these residues disrupts the high affinity site (Figs. 5 and 6). As we used single Boltzmann functions for data analysis, our data suggest that there is one low affinity site after mutation of the high affinity site Glu1047/Glu1052.
Analysis of the voltage-dependent effects of Mg2+/Ca2+ suggests that the high affinity site is located at about 84% of the electrical distance of membrane, similar to the value estimated by Kerschbaum and colleagues (35) for the MIC/TRPM7 channel. The fractional electrical distance from the outside surface of the membrane δout estimated based on the Mg2+ block changes from 0.84 in WT TRPM7 (Fig. 6) to 0.36 in E1047Q, and 0.52 in E1052Q. In the double mutant, the δout (0.44) is close but not identical to that of E1047Q or E1052Q, suggesting that a low affinity site is located between δout of 0.36 and 0.52. The differences in δout for the potential low affinity site may be a reflection of experimental variations, or may represent reorganization of the pore structure after mutating of Glu1047, Glu1052, and Glu1047/Glu1052. In addition, we used the simplest model for data analysis, which assumes one permeant ion occupies a binding site in the channel pore (50). This may also contribute to the variances in estimated δout for the low affinity site. Nonetheless, our data indicate that a low affinity site is located close to the outer surface of the cell membrane. Taken together, our results suggest that a high affinity binding site comprising Glu1047 and Glu1052 is located deep within the pore (82 to 84%), whereas a low affinity binding site is shallower, within 36 –52% of the electrical distance of membrane.
Selectivity Filter of TRPM6 and TRPM7
TRP channels vary from each other by their gating mechanisms and permeability profiles. TRPV5 and TRPV6 have the highest Ca2+ selectivity (51), whereas TRPM4 and TRPM5 are monovalent selective and impermeable to divalent cations (52–55). Similar to VGCCs, the Ca2+ selectivity of TRPV5/TRPV6 is determined by a single pore residue, Asp542 (43). The acidic residues in the putative pore of TRPV1 (Asp646) (44) and TRPV4 (Asp682) (46) are also involved in divalent permeability. The pore structure of TRPM channels is less well defined (51). A recent study by Nilius and colleagues (56) revealed that an acidic stretch of six residues (981EDMDVA986) between TM5 and TM6 is the selectivity filter for TRPM4. According to our sequence alignment, the selectivity filter of TRPM4 corresponds to the region between residues 1051YEIDVC1056 in TRPM7 and 1028GEI-DVC1033 in TRPM6. Different from this prediction, our data indicate the residues critical to ion selectivity in the pore region are 1047EVYAYE1052 for TRPM7 and 1024EVYAGE1029 for TRPM6. We demonstrate that the E1047Q mutant produced the most dramatic changes in TRPM7 channel properties. Not only does E1047Q eliminate Ca2+ and Mg2+ permeation, but it also abolishes a proton-induced increase in inward currents. Thus, the Glu1047 residue should be considered a key component of the selectivity filter. In addition to E1047Q, E1052Q also influenced Ca2+/Mg2+ permeability. Furthermore, the double mutant E1047Q/E1052Q exhibited similar properties to those of E1047Q. Therefore, it is likely the Glu1047 and Glu1052 residues form a high affinity binding site for divalent cations. Asp1054 is a conserved residue in all TRPM channels. However, the exchange of Asp at position 1054 for Ala (D1054A) did not alter the apparent affinity for Ca2+ and Mg2+. The negatively charged residue preceding Glu1047, Asp1035, has no influence on Ca2+ and Mg2+ permeability and selectivity. Therefore, our results predict that the selectivity filter of TRPM7 lies between Glu1047 and Glu1052 (or Glu1024–Glu1029 for TRPM6).
The negatively charged residue Glu1047 is conserved in TRPM1, TRPM3, TRPM6, and TRPM7. Interestingly, mutation of Gln977 by Glu in TRPM4, the analogous residue to Glu1047 in TRPM7, altered the monovalent cation permeability sequence and rendered the TRPM4 pore permeable to Ca2+ (56), suggesting that the Glu1047 position is indeed crucial for determining the divalent selectivity of TRPM channels. It will be of interest to investigate whether mutation of this conserved residue influences the divalent permeability of TRPM1 and TRPM3 as well. Nonetheless, it seems that the pore structure of TRPM channels is more complicated than first imagined. For example, Oberwinkler and colleagues (57) recently identified several TRPM3 spliced variants, TRPM3α1–5. Whereas the TRPM3α-2 displays high permeability to Ca2+ and Mg2+, TRPM3α-1, which includes an additional stretch of 12 amino acids following the invariant Asp, a residue equivalent to Asp1054 in TRPM7, exhibited a more than 10-fold lower permeability for divalent cations (57). This could be attributed to a possibility that the additional 12 residues result in re-arrangement of the pore structure. Because Asp1054 is conserved in all the TRPM channels, including both divalent permeable and monovalent selective (TRPM4 –5) ones, it may be less influential than Glu1047 and Glu1052 on divalent selectivity. Taken together, our results suggest that 1047EVYAYE1052 in TRPM7 and 1024EVY-AGE1029 in TRPM6 constitute the selectivity filter, and that Glu1047/Glu1024 and Glu1052/Glu1029 are essential for Ca2+/Mg2+ selectivity and pH sensitivity.
Conclusions
The importance of Mg2+ and Ca2+ permeation of TRPM6 and TRPM7 has been well demonstrated. Mutations in TRPM6 lead to familial hypomagnesemia and secondary hypocalcemia (20, 21), and deletion of TRPM7 causes cell death (7, 10, 22). Moreover, it has been demonstrated recently that the sensitivity of TRPM7 to external pH may contribute to the ability of the channel to control neurotransmitter release (28). In the present study, we provide strong evidence demonstrating that the amino acid residues Glu1024/Glu1047 and Glu1029/Glu1052 in the putative pore region of TRPM6 and TRPM7 are essential for their Ca2+ and Mg2+ permeability and pH sensitivity. These findings provide the molecular mechanisms by which TRPM6 and TRPM7 exert their physiological functions, and may in fact serve as a platform for future work aimed at discovering pharmacological agents to manipulate TRPM6 and TRPM7 channel functions. In addition, our results provide valuable information on the pore architecture of TRPM6 and TRPM7 channels, knowledge that will help guide future investigations into the complex nature of TRPM channel family members.
Addendum
After this article was submitted, and while it was being revised, we learned of a relevant paper about the molecular determinants of TRPM6 permeation (58). The results of that study also indicate that the negative charged residues are important for TRPM6 permeation properties.
Supplementary Material
Acknowledgments
We thank Dr. Joost G. J. Hoenderop for providing TRPM6 in the pCINeo/IRES-GFP vector; Dr. Nilius for providing TRPM4 and its mutant Q977E; Drs. David Clapham, Alan Fein, Haoxing Xu, and Dejian Ren for constructive suggestions and comments.
Footnotes
This work was supported by American Heart Association Grant 0335124N and National Institutes of Health Grant HL078960 (to L. Y.).
The on-line version of this article (available at http://www.jbc.org) contains supplemental Tables S1 and S2 and Fig. S1.
The abbreviations used are: WT, wild type; VGCC, voltage-gated Ca2+ channels; DVF, divalent-free solution; NMDG, N-methyl-D-glucamine; MES, 4-morpholineethanesulfonic acid.
References
- 1.Harteneck C, Plant TD, Schultz G. Trends Neurosci. 2000;23:159–166. doi: 10.1016/s0166-2236(99)01532-5. [DOI] [PubMed] [Google Scholar]
- 2.Clapham DE. Nature. 2003;426:517–524. doi: 10.1038/nature02196. [DOI] [PubMed] [Google Scholar]
- 3.Fleig A, Penner R. Novartis Found Symp. 2004;258:248–258. 258–266. [PubMed] [Google Scholar]
- 4.Schmitz C, Perraud AL, Fleig A, Scharenberg AM. Pediatr Res. 2004;55:734–737. doi: 10.1203/01.PDR.0000117848.37520.A2. [DOI] [PubMed] [Google Scholar]
- 5.Montell C. Sci STKE. 2005;2005:1–24. [Google Scholar]
- 6.Runnels LW, Yue L, Clapham DE. Science. 2001;291:1043–1047. doi: 10.1126/science.1058519. [DOI] [PubMed] [Google Scholar]
- 7.Nadler MJ, Hermosura MC, Inabe K, Perraud AL, Zhu Q, Stokes AJ, Kurosaki T, Kinet JP, Penner R, Scharenberg AM, Fleig A. Nature. 2001;411:590–595. doi: 10.1038/35079092. [DOI] [PubMed] [Google Scholar]
- 8.Voets T, Nilius B, Hoefs S, van der Kemp AWCM, Droogmans G, Bindels RJM, Hoenderop JGJ. J Biol Chem. 2004;279:19–25. doi: 10.1074/jbc.M311201200. [DOI] [PubMed] [Google Scholar]
- 9.Chubanov V, Waldegger S, Mederos y Schnitzler M, Vitzthum H, Sassen MC, Seyberth HW, Konrad M, Gudermann T. Proc Natl Acad Sci U S A. 2004;101:2894–2899. doi: 10.1073/pnas.0305252101. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Schmitz C, Dorovkov MV, Zhao X, Davenport BJ, Ryazanov AG, Perraud AL. J Biol Chem. 2005;280:37763–37771. doi: 10.1074/jbc.M509175200. [DOI] [PubMed] [Google Scholar]
- 11.Li M, Jiang J, Yue L. J Gen Physiol. 2006;127:525–537. doi: 10.1085/jgp.200609502. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Monteilh-Zoller MK, Hermosura MC, Nadler MJ, Scharenberg AM, Penner R, Fleig A. J Gen Physiol. 2003;121:49–60. doi: 10.1085/jgp.20028740. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Kozak JA, Cahalan MD. Biophys J. 2003;84:922–927. doi: 10.1016/S0006-3495(03)74909-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Kozak JA, Matsushita M, Nairn AC, Cahalan MD. J Gen Physiol. 2005;126:499–514. doi: 10.1085/jgp.200509324. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Kozak JA, Cahalan MD. Biophys J. 2004;86:63. (abstr.) [Google Scholar]
- 16.Hermosura MC, Monteilh-Zoller MK, Scharenberg AM, Penner R, Fleig A. J Physiol. 2002;539:445–458. doi: 10.1113/jphysiol.2001.013361. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Runnels LW, Yue L, Clapham DE. Nat Cell Biol. 2002;4:329–336. doi: 10.1038/ncb781. [DOI] [PubMed] [Google Scholar]
- 18.Takezawa R, Schmitz C, Demeuse P, Scharenberg AM, Penner R, Fleig A. Proc Natl Acad Sci U S A. 2004;101:6009–6014. doi: 10.1073/pnas.0307565101. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Jiang J, Li M, Yue L. J Gen Physiol. 2005;126:137–150. doi: 10.1085/jgp.200409185. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Walder RY, Landau D, Meyer P, Shalev H, Tsolia M, Borochowitz Z, Boettger MB, Beck GE, Englehardt RK, Carmi R, Sheffield VC. Nat Genet. 2002;31:171–174. doi: 10.1038/ng901. [DOI] [PubMed] [Google Scholar]
- 21.Schlingmann KP, Weber S, Peters M, Niemann Nejsum L, Vitzthum H, Klingel K, Kratz M, Haddad E, Ristoff E, Dinour D, Syrrou M, Nielsen S, Sassen M, Waldegger S, Seyberth HW, Konrad M. Nat Genet. 2002;31:166–170. doi: 10.1038/ng889. [DOI] [PubMed] [Google Scholar]
- 22.Schmitz C, Perraud AL, Johnson CO, Inabe K, Smith MK, Penner R, Kurosaki T, Fleig A, Scharenberg AM. Cell. 2003;114:191–200. doi: 10.1016/s0092-8674(03)00556-7. [DOI] [PubMed] [Google Scholar]
- 23.Chubanov V, Gudermann T, Schlingmann KP. Pflügers Arch. 2005;451:228–234. doi: 10.1007/s00424-005-1470-y. [DOI] [PubMed] [Google Scholar]
- 24.Aarts M, Iihara K, Wei WL, Xiong ZG, Arundine M, Cerwinski W, MacDonald JF, Tymianski M. Cell. 2003;115:863–877. doi: 10.1016/s0092-8674(03)01017-1. [DOI] [PubMed] [Google Scholar]
- 25.Su LT, Agapito MA, Li M, Simonson WT, Huttenlocher A, Habas R, Yue L, Runnels LW. J Biol Chem. 2006;281:11260–11270. doi: 10.1074/jbc.M512885200. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Clark K, Langeslag M, van Leeuwen B, Ran L, Ryazanov AG, Figdor CG, Moolenaar WH, Jalink K, van Leeuwen FN. EMBO J. 2006;25:290–301. doi: 10.1038/sj.emboj.7600931. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Elizondo MR, Arduini BL, Paulsen J, MacDonald EL, Sabel JL, Henion PD, Cornell RA, Parichy DM. Curr Biol. 2005;15:667–671. doi: 10.1016/j.cub.2005.02.050. [DOI] [PubMed] [Google Scholar]
- 28.Krapivinsky G, Mochida S, Krapivinsky L, Cibulsky SM, Clapham DE. Neuron. 2006;52:485–496. doi: 10.1016/j.neuron.2006.09.033. [DOI] [PubMed] [Google Scholar]
- 29.Yue L, Navarro B, Ren D, Ramos A, Clapham D. J Gen Physiol. 2002;160:845–853. doi: 10.1085/jgp.20028699. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Jordt SE, Tominaga M, Julius D. Proc Natl Acad Sci U S A. 2000;97:8134–8139. doi: 10.1073/pnas.100129497. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Askwith CC, Wemmie JA, Price MP, Rokhlina T, Welsh MJ. J Biol Chem. 2004;279:18296–18305. doi: 10.1074/jbc.M312145200. [DOI] [PubMed] [Google Scholar]
- 32.Yermolaieva O, Leonard AS, Schnizler MK, Abboud FM, Welsh MJ. Proc Natl Acad Sci U S A. 2004;101:6752–6757. doi: 10.1073/pnas.0308636100. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Hille B. Ion Channels of Excitable Membranes. 3. Sinauer Associates, Inc; Sunderland, MA: 2003. [Google Scholar]
- 34.Yue L, Peng JB, Hediger MA, Clapham DE. Nature. 2001;410:705–709. doi: 10.1038/35070596. [DOI] [PubMed] [Google Scholar]
- 35.Kerschbaum HH, Kozak JA, Cahalan MD. Biophys J. 2003;84:2293–2305. doi: 10.1016/S0006-3495(03)75035-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Kerschbaum HH, Cahalan MD. J Gen Physiol. 1998;111:521–537. doi: 10.1085/jgp.111.4.521. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Tikhonov DB, Magazanik LG. J Membr Biol. 1998;161:1–8. doi: 10.1007/s002329900309. [DOI] [PubMed] [Google Scholar]
- 38.Ellinor PT, Yang J, Sather WA, Zhang JF, Tsien RW. Neuron. 1995;15:1121–1132. doi: 10.1016/0896-6273(95)90100-0. [DOI] [PubMed] [Google Scholar]
- 39.Demeuse P, Penner R, Fleig A. J Gen Physiol. 2006;127:421–434. doi: 10.1085/jgp.200509410. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Vennekens R, Hoenderop JGJ, Prenen J, Stuiver M, Willems PHGM, Droogmans G, Nilius B, Bindels RJM. J Biol Chem. 2000;275:3963–3969. doi: 10.1074/jbc.275.6.3963. [DOI] [PubMed] [Google Scholar]
- 41.Vennekens R, Prenen J, Hoenderop JG, Bindels RJ, Droogmans G, Nilius B. Pflügers Arch. 2001;442:237–242. doi: 10.1007/s004240100517. [DOI] [PubMed] [Google Scholar]
- 42.Yeh BI, Sun TJ, Lee JZ, Chen HH, Huang CL. J Biol Chem. 2003;278:51044–51052. doi: 10.1074/jbc.M306326200. [DOI] [PubMed] [Google Scholar]
- 43.Nilius B, Vennekens R, Prenen J, Hoenderop JG, Droogmans G, Bindels RJ. J Biol Chem. 2001;276:1020–1025. doi: 10.1074/jbc.M006184200. [DOI] [PubMed] [Google Scholar]
- 44.Garcia-Martinez C, Morenilla-Palao C, Planells-Cases R, Merino JM, Ferrer-Montiel A. J Biol Chem. 2000;275:32552–32558. doi: 10.1074/jbc.M002391200. [DOI] [PubMed] [Google Scholar]
- 45.Suzuki M, Mizuno A, Kodaira K, Imai M. J Biol Chem. 2003;278:22664–22668. doi: 10.1074/jbc.M302561200. [DOI] [PubMed] [Google Scholar]
- 46.Voets T, Prenen J, Vriens J, Watanabe H, Janssens A, Wissenbach U, Bodding M, Droogmans G, Nilius B. J Biol Chem. 2002;277:33704–33710. doi: 10.1074/jbc.M204828200. [DOI] [PubMed] [Google Scholar]
- 47.Liu D, Zhang Z, Liman ER. J Biol Chem. 2005;280:20691–20699. doi: 10.1074/jbc.M414072200. [DOI] [PubMed] [Google Scholar]
- 48.Chen XH, Bezprozvanny I, Tsien RW. J Gen Physiol. 1996;108:363–374. doi: 10.1085/jgp.108.5.363. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Chen XH, Tsien RW. J Biol Chem. 1997;272:30002–30008. doi: 10.1074/jbc.272.48.30002. [DOI] [PubMed] [Google Scholar]
- 50.Woodhull AM. J Gen Physiol. 1973;61:687–708. doi: 10.1085/jgp.61.6.687. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Owsianik G, Talavera K, Voets T, Nilius B. Annu Rev Physiol. 2006;68:685–717. doi: 10.1146/annurev.physiol.68.040204.101406. [DOI] [PubMed] [Google Scholar]
- 52.Launay P, Fleig A, Perraud AL, Scharenberg AM, Penner R, Kinet JP. Cell. 2002;109:397–407. doi: 10.1016/s0092-8674(02)00719-5. [DOI] [PubMed] [Google Scholar]
- 53.Liu D, Liman ER. Proc Natl Acad Sci U S A. 2003;100:15160–15165. doi: 10.1073/pnas.2334159100. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Prawitt D, Monteilh-Zoller MK, Brixel L, Spangenberg C, Zabel B, Fleig A, Penner R. Proc Natl Acad Sci U S A. 2003;100:15166–15171. doi: 10.1073/pnas.2334624100. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Hofmann T, Chubanov V, Gudermann T, Montell C. Curr Biol. 2003;13:1153–1158. doi: 10.1016/s0960-9822(03)00431-7. [DOI] [PubMed] [Google Scholar]
- 56.Nilius B, Prenen J, Janssens A, Owsianik G, Wang C, Zhu MX, Voets T. J Biol Chem. 2005;280:22899–22906. doi: 10.1074/jbc.M501686200. [DOI] [PubMed] [Google Scholar]
- 57.Oberwinkler J, Lis A, Giehl KM, Flockerzi V, Philipp SE. J Biol Chem. 2005;280:22540–22548. doi: 10.1074/jbc.M503092200. [DOI] [PubMed] [Google Scholar]
- 58.Topala CN, Groenestege WT, Thebault S, van den Berg D, Nilius B, Hoenderop JG, Bindels RJ. Cell Calcium. 2007;41:513–523. doi: 10.1016/j.ceca.2006.10.003. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.